PRNP and prion disease: Preliminary immunotherapy research in 2001 showed that prolonged exposure (6 weeks) of ScN2a cells to mAb 6H4 (specific for aa 144–152 on the prion protein) resulted in the complete clearance of PrPSc offering evidence that anti-PrP Abs have the potential to interfere with the prion disease process [177].